Johnson & Johnson

U.S. multinational manufacturer of pharmaceuticals and medical devices

JNJ NYSE ISIN US4781601046 SEC CIK 200406 LEI 549300G0CFPGEF6X2043
Follow Johnson & Johnson Weekly email: filings, results

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$25B$50B$75B$100BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$94.2B$26.8B
FY25$88.8B$14.1B
FY24$85.2B$35.2B
FY23$80B$17.9B
FY22$78.7B$20.9B
FY21$82.6B$14.7B
FY20$82.1B$15.1B
FY19$81.6B$15.3B
FY18$76.5B$1.3B
FY17$71.9B$16.5B
FY16$70.1B$15.4B
FY15$74.3B$16.3B
FY14$71.3B$13.8B
FY13$67.2B$10.9B
FY12$65B$9.7B
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2667.9%-28.5%
FY2569.1%-15.8%
FY2468.8%-41.3%
FY2369.3%-22.4%
FY2270.3%-26.5%
FY2165.6%-17.8%
FY2066.4%-18.4%
FY1966.8%-18.8%
FY1866.7%-1.7%
FY1769.7%-23%
FY1669.3%-22%
FY1569.4%29%22%
FY1468.7%23%19.4%
FY1367.8%22.2%16.1%
FY1268.7%21.2%14.9%
Free cash flowOperating cash flow minus capital expenditure
$0$10B$20B$30BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26$19.7B
FY25$19.8B
FY24$18.2B
FY23$17.2B
FY22$19.8B
FY21$20.2B
FY20$19.9B
FY19$18.5B
FY18$17.8B
FY17$15.5B
FY16$16.1B
FY15$15B
FY14$13.8B
FY13$12.5B
FY12$11.4B
Returned to shareholdersDividends paid and shares bought back
$0$5B$10B$15BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearBuybacks
FY26$6B
FY25$2.4B
FY24$5.1B
FY23$6B
FY22$3.5B
FY21$3.2B
FY20$6.7B
FY19$5.9B
FY18$6.4B
FY17$9B
FY16$5.3B
FY15$7.1B
FY14$3.5B
FY13$12.9B
FY12$2.5B
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Johnson & Johnson
  • Healthcare median
−100%−50%0%50%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearJohnson & JohnsonHealthcare median
FY2628.5%−11.1%
FY2515.8%−30.6%
FY2441.3%−47%
FY2322.4%−58%
FY2226.5%−80.4%
FY2117.8%−71.9%
FY2018.4%−62.2%
FY1918.8%−46.3%
FY181.7%−49.6%
FY1723%−45.9%
FY1622%−36%
FY1522%−38.4%
FY1419.4%−35.5%
FY1316.1%−37.1%
FY1214.9%−29.1%